Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Performance of small diameter synthetic vascular prostheses with confluent autologous endothelial cell linings.

Poole-Warren LA, Schindhelm K, Graham AR, Slowiaczek PR, Noble KR.

J Biomed Mater Res. 1996 Feb;30(2):221-29.

PMID:
9019487
2.

An experimental model of affinity cell separation.

Nordon RE, Milthorpe BK, Schindhelm K, Slowiaczek PR.

Cytometry. 1994 May 1;16(1):25-33.

3.

In vivo patency of endothelial cell-lined expanded polytetrafluoroethylene prostheses in an ovine model.

James NL, Schindhelm K, Slowiaczek P, Milthorpe B, Graham AR, Munro VF, Johnson G, Steele JG.

Artif Organs. 1992 Aug;16(4):346-53.

PMID:
10078273
4.

Beta 2-microglobulin kinetics in end-stage renal failure.

Odell RA, Slowiaczek P, Moran JE, Schindhelm K.

Kidney Int. 1991 May;39(5):909-19.

5.

Endothelial cell seeding of small diameter vascular grafts.

James NL, Schindhelm K, Slowiaczek P, Milthorpe BK, Dudman NP, Johnson G, Steele JG.

Artif Organs. 1990 Oct;14(5):355-60.

PMID:
2241603
6.

Effect of gallium on DNA synthesis by human T-cell lymphoblasts.

Hedley DW, Tripp EH, Slowiaczek P, Mann GJ.

Cancer Res. 1988 Jun 1;48(11):3014-8.

7.

Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells.

Muggia FM, Slowiaczek P, Tattersall MH.

Anticancer Res. 1987 Mar-Apr;7(2):161-6.

PMID:
3592628
8.

Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake.

Taylor IW, Slowiaczek P, Friedlander ML, Tattersall MH.

Cancer Res. 1985 Mar;45(3):978-82.

9.

Deoxyuridine metabolism in cultured human lymphoblasts treated with methotrexate.

Perez DJ, Slowiaczek P, Tattersall MH.

Cancer Res. 1984 Feb;44(2):457-60.

10.

Regional variation in extracellular purine levels in vivo.

Tattersall MH, Slowiaczek P, De Fazio A.

Adv Exp Med Biol. 1984;165 Pt A:301-4. No abstract available.

PMID:
6720393
11.

Regional variation in human extracellular purine levels.

Tattersall MH, Slowiaczek P, De Fazio A.

J Lab Clin Med. 1983 Sep;102(3):411-20.

PMID:
6688440
12.

Purine modulation of methotrexate cytotoxicity in mammalian cell lines.

Taylor IW, Slowiaczek P, Francis PR, Tattersall MH.

Cancer Res. 1982 Dec;42(12):5159-64.

13.

The determination of purine levels in human and mouse plasma.

Slowiaczek P, Tattersall MH.

Anal Biochem. 1982 Sep 1;125(1):6-12. No abstract available.

PMID:
6897341
14.

Methotrexate rescue by 5-methyltetrahydrofolate or 5-formyltetrahydrofolate in lymphoblast cell lines.

Dudman NP, Slowiaczek P, Tattersall MH.

Cancer Res. 1982 Feb;42(2):502-7.

15.

Biochemical and cell cycle perturbations in methotrexate-treated cells.

Taylor IW, Slowiaczek P, Francis PR, Tattersall MH.

Mol Pharmacol. 1982 Jan;21(1):204-10.

PMID:
6982394

Supplemental Content

Loading ...
Support Center